Founded in Melbourne by Dr. Thomas Kelly, Yu Liu, and Waleed Mussa, Heidi grew from an ambient AI scribe into a broader AI Care Partner platform for clinicians. Its documentation software captures patient encounters in more than 110 languages, produces structured clinical notes, transfers them to electronic health records, and supports coding workflows, with reported millions of patient interactions per week across 190 countries.
The product family spans Heidi Scribe for ambient documentation, Heidi Evidence for point-of-care reference with cited answers and validated calculators, and Heidi Remote, a clip-on offline dictation microphone. Heidi has disclosed roughly US$97M in funding, including a US$65M Series B led by Point72 Private Investments in October 2025 at a US$465M valuation, and in February 2026 acquired UK clinical-AI developer AutoMedica alongside launching Heidi Evidence.
